HealthQuad is India's leading healthcare-focused venture capital firm, incubated in 2016 by Quadria Capital. It invests in early-growth-stage technology-enabled healthcare companies across healthtech, medtech, novel healthcare delivery, and bio/pharmtech, with its second fund having closed at $162 million.
33% of their portfolio is in Healthcare. Average disclosed round size is $37.1M (across 15 rounds with reported amounts).
Portfolio
15
Fund Size
$162M
Top Stage
Series B
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
18 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| BBoston Ivy Healthcare Solutions Private Limited | Unknown | — | Feb 2026 |
| QQure.ai | Series D | $65M | Sep 2024 |
 Cureskin | Series B | $5M | Jan 2024 |
| RRedcliffe | Growth | $61M | Jan 2024 |
 Wysa | Series B | $20M | Jul 2022 |
 Redcliffe Lifetech | Growth | $61M | Jan 2022 |
| BBoston Ivy Healthcare Solutions Private Limited | Series D | $65M | Jan 2022 |
 HealthifyMe | Series C | $75M | Jul 2021 |
| RRegency Health | Unknown | — | Jan 2016 |
 Ekincare | Series B | $15M | — |
| Redcliffe Lifetech | Series B | $61M | — |
 Stanplus | Series A | $20M | — |
 RED.Health | Series A | $20M | — |
| SSekhmet Technologies Pvt. Ltd | Seed | $2.1M | — |
| RRedcliffe | Series C | $42M | — |
| HHealthifyme Pte Ltd | Series C | $30M | — |
 Regency Hospital | Unknown | $14M | — |
| AAsian Institute of Nephrology and Urology (AINU) | Growth | — | — |
Top Co-Investors
LeapFrog Investments6 shared
British International Investment6 shared
Chiratae Ventures4 shared
Khosla Ventures3 shared
India Quotient3 shared
Schroders Capital3 shared
Elm2 shared
Unilever Ventures2 shared
Inventus Capital Partners2 shared
Y Combinator2 shared
Kalaari Capital2 shared
Blume Ventures2 shared
Rakuten Capital2 shared
TEAMFund1 shared
360 ONE Asset1 shared
Kae Capital1 shared
Lightspeed Venture Partners1 shared
Novo Holdings A/S1 shared
Last updated: 8 September 2026